Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Adverum Biotechnologies, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ADVM is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 50
- −9 vs. Q2 2025
- Shares held
- 14.1M
- +63.5K (+0.5%) vs. Q2 2025
- Total value
- $63.8M
- +$33.6M (+111.6%) vs. Q2 2025
- New holders
- 6
- 7 more added
- Sold out
- 15
- 23 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 33 | $0 | 0.00% | −2,120−98.5% | Reduced |
| Deutsche Bank AG | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 1 | $5 | 0.00% | +1 | New |
| SRS Capital Advisors, Inc. | 19 | $86 | 0.00% | +19 | New |
| GHP Investment Advisors, Inc. | 20 | $91 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 21 | $96 | 0.00% | +21 | New |
| Wells Fargo & Company | 30 | $136 | 0.00% | −184−86.0% | Reduced |
| Parallel Advisors, LLC | 50 | $227 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 84 | $381 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 102 | $463 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 182 | $824 | 0.00% | +182 | New |
| UMA Financial Services, Inc. | 217 | $984 | 0.00% | +217 | New |
| BNP Paribas Arbitrage, SA | 540 | $2.45K | 0.00% | −246−31.3% | Reduced |
| Jones Financial Companies LLLP | 1,000 | $4.51K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,689 | $7.69K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,933 | $8.76K | 0.00% | −391−16.8% | Reduced |
| Bank of America Corp | 3,614 | $16.4K | 0.00% | −37,652−91.2% | Reduced |
| UBS Group AG | 5,585 | $25.3K | 0.00% | −8,585−60.6% | Reduced |
| Squarepoint Ops LLC | 11,271 | $51.1K | 0.00% | −10,381−47.9% | Reduced |
| XTX Topco Ltd | 12,655 | $57.3K | 0.00% | −17,100−57.5% | Reduced |
| JustInvest LLC | 12,805 | $58.0K | 0.00% | +12,805 | New |
| Royal Bank of Canada | 13,465 | $61.0K | 0.00% | +10,696+386.3% | Added |
| D. E. Shaw & Co., Inc. | 17,153 | $77.7K | 0.00% | −9,599−35.9% | Reduced |
| Citadel Advisors LLC | 17,267 | $78.2K | 0.00% | −61,004−77.9% | Reduced |
| Morgan Stanley | 17,555 | $79.5K | 0.00% | −35,382−66.8% | Reduced |
| Qube Research & Technologies Ltd | 21,730 | $98.4K | 0.00% | −8,949−29.2% | Reduced |
| Susquehanna International Group, LLP | 26,255 | $118.9K | 0.00% | −32,956−55.7% | Reduced |
| Northern Trust Corp | 28,058 | $127.1K | 0.00% | −6,333−18.4% | Reduced |
| Marshall Wace, LLP | 28,367 | $128.5K | 0.00% | −21,261−42.8% | Reduced |
| Two Sigma Advisers, LP | 38,071 | $172.5K | 0.00% | +27,390+256.4% | Added |
| Quinn Opportunity Partners LLC | 41,418 | $187.6K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 68,734 | $311.4K | 0.00% | −90−0.1% | Reduced |
| Two Sigma Investments, LP | 88,670 | $401.7K | 0.00% | +69,913+372.7% | Added |
| Warren Averett Asset Management, LLC | 160,991 | $729.3K | 0.01% | +413+0.3% | Added |
| Regeneron Pharmaceuticals, Inc. | 180,909 | $819.5K | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 184,762 | $837.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 234,541 | $1.06M | 0.00% | −51,509−18.0% | Reduced |
| Soleus Capital Management, L.P. | 287,246 | $1.30M | 0.07% | 00.0% | Unchanged |
| BlackRock, Inc. | 311,394 | $1.41M | 0.00% | −103,091−24.9% | Reduced |
| Millennium Management LLC | 324,422 | $1.47M | 0.00% | −17,918−5.2% | Reduced |
| Pale Fire Capital SE | 363,282 | $1.65M | 0.18% | +4,558+1.3% | Added |
| Renaissance Technologies LLC | 363,496 | $1.65M | 0.00% | −207,173−36.3% | Reduced |
| Goldman Sachs Group Inc | 402,581 | $1.82M | 0.00% | −94,706−19.0% | Reduced |
| Versant Venture Management, LLC | 506,821 | $2.30M | 1.08% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 541,666 | $2.45M | 0.90% | 00.0% | Unchanged |
| Vanguard Group Inc | 872,041 | $3.95M | 0.00% | −11,896−1.3% | Reduced |
| TCG Crossover Management, LLC | 1,668,174 | $7.56M | 0.37% | −128,308−7.1% | Reduced |
| Frazier Life Sciences Management, L.P. | 2,077,431 | $9.41M | 0.28% | +1,008,187+94.3% | Added |
| Principia Wealth Advisory, LLC | 2,077,946 | $9.41M | 6.72% | +48,830+2.4% | Added |
| BML Capital Management, LLC | 3,057,526 | $13.9M | 12.74% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −70,931−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −67,602−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −30,627−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −21,819−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −21,122−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −14,582−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −10,670−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,137−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,916−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Eq Wealth Advisors, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |